Early intervention

The goal of treating multiple sclerosis (MS) should be to preserve brain tissue and maximize lifelong brain health by reducing disease activity. In people with relapsing forms of MS, starting treatment with a disease-modifying therapy (DMT) early in the disease course is associated with better long-term outcomes than delaying treatment. Therefore, we recommend a therapeutic strategy involving early intervention with a DMT, where appropriate.

The articles in this section explain the scientific evidence for intervening as early as possible in the disease course.